Small Cell Lung Cancer

A team of pulmonologists, medical oncologists, radiation oncologists, and thoracic surgeons works quickly to create a customized treatment plan for small cell lung cancer. This may include chemotherapy, radiation therapy, surgery, or endobronchial stenting, which clears blocked airways.

As part of a multidisciplinary medical center, we can offer you treatments not only for cancer, but for a full range of other medical conditions.

We also offer a variety of support services to improve quality of life and complement the comprehensive and compassionate care we provide. This may include pulmonary rehabilitation, smoking cessation, psychological and social support, and integrative therapies.

Clinical Trials and Research Studies

Phase N/A

An Open-Label Multi-Center Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE)

Learn More

Phase 2

An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-na ve EGFR-mutant Locally Advanced or Metastatic NSCLC

Learn More

Phase 2

The Selective Personalized Radio-Immunotherapy for locally advanced NSCLC Trial (SPRINT)

Learn More

Phase 3

Phase III randomized double-blind placebo-controlled multi-centre study assessing the efficacy and safety of durvalumab versus placebo as treatment following SBRT in patients with Stage I/II non small cell lung cancer.

Learn More